共 92 条
[1]
Flanigan KM(2012)The muscular dystrophies Semin Neurol 32 255-263
[2]
Balaban B(2005)Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect Am J Phys Med Rehabil 84 843-850
[3]
Matthews DJ(2004)Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis Eur J Neurol 11 541-544
[4]
Clayton GH(2018)Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management Lancet Neurol 17 347-361
[5]
Carry T(2014)Age-specific prevalence of osteoporosis and frequency of poor bone health indices in Duchenne muscular dystrophy Neuromuscul Disord 24 857-104
[6]
Yilmaz O(2007)The RANKL/RANK/OPG pathway Curr Osteoporos Rep 5 98-146
[7]
Karaduman A(2008)Functions of RANKL/RANK/OPG in bone modeling and remodeling Arch Biochem Biophys 473 139-983
[8]
Topaloglu H(2007)Biology of RANK, RANKL, and osteoprotegerin Arthritis Res Ther 9 S1-1643
[9]
Birnkrant DJ(2007)RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis Arthritis Rheum 56 977-2075
[10]
Bushby K(2010)Serum levels of osteoprotegerin and receptor activator of nuclear factor -kappaB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study Pediatr Rheumatol Online J 8 30-422